17-7307116-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 8P and 4B. PVS1_StrongPP3_StrongBS2
The ENST00000336452.11(EIF5A):c.69+1G>A variant causes a splice donor change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000207 in 1,595,882 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/2 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
ENST00000336452.11 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EIF5A | NM_001143760.1 | c.69+1G>A | splice_donor_variant | ||||
EIF5A | NM_001370420.1 | c.-22+3G>A | splice_donor_region_variant, intron_variant | ||||
EIF5A | XM_017024301.3 | c.-29+3G>A | splice_donor_region_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EIF5A | ENST00000336452.11 | c.69+1G>A | splice_donor_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152266Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000222 AC: 32AN: 1443616Hom.: 0 Cov.: 30 AF XY: 0.0000251 AC XY: 18AN XY: 716680
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152266Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74394
ClinVar
Submissions by phenotype
Faundes-Banka syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 26, 2024 | - - |
EIF5A-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 03, 2023 | The EIF5A c.69+1G>A variant is predicted to disrupt the GT donor site and interfere with normal splicing. However, this variant affects an alternative transcript with evidence of low expression (https://gtexportal.org/). In the canonical transcript, this variant is pre-coding (NM_001970:c.-658G>A). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0017% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/17-7210435-G-A). Loss of function is not an established mechanism of EIF5A-related disease. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at